Axos Financial director Nick Mosich sells $124,950 in shares

Axos Financial director Nick Mosich sold 1,275 shares for $124,950 at $98 per share on February 17, 2026, while retaining direct ownership of 64,849 shares; AX subsequently traded at $92.54. The company reported fiscal Q4 2026 diluted EPS of $2.53 versus $2.16 consensus and revenue of $379.77 million versus $376.59 million expected, supported by loan growth, higher net interest margin, and lower credit costs. Analysts raised or maintained targets in a $110-$128 range, implying meaningful upside from the current share price.

Analysis

AX’s near-term setup hinges less on the insider filing than on whether its asset-sensitive balance sheet can retain incremental yield without a commensurate rise in deposit beta. A renewed tightening cycle initially supports net interest income for digitally originated lenders with floating-rate and short-duration assets, but the benefit typically peaks after 1-2 quarters as online deposit competition reprices. The relevant read-through is not headline NIM but the sequential change in deposit costs, noninterest-bearing deposit mix, and loan yields versus broader regional-bank funding pressure.

The earnings beat raises the risk that consensus is extrapolating unusually benign credit costs into a more restrictive policy environment. AX’s differentiated underwriting and diversified loan book can sustain a valuation discount to high-quality compounders only if criticized/classified loans, net charge-offs, and provision expense remain controlled; a 25-50 bp adverse turn in credit costs would be disproportionately material to earnings and multiple support. Higher rates also pressure rate-sensitive commercial real estate borrowers and leveraged consumers with a lag of 6-18 months, making stable current credit metrics a lagging rather than leading indicator.

The director transaction is economically immaterial relative to the remaining ownership and should not be treated as a signal absent coordinated selling or a change in executive purchase activity. Consensus upside targets appear to assume continued operating leverage and clean credit; the non-obvious risk is that a hawkish Fed makes both assumptions harder simultaneously, compressing NIM through funding costs while increasing provisions. Conversely, AX can outperform regional-bank peers over the next 1-3 months if deposit migration remains limited and management demonstrates that loan growth is not being purchased through looser pricing or underwriting.

A broad regional-bank long is not warranted solely on a rate hike: higher policy rates are more favorable to banks with low deposit beta and limited duration/CRE exposure, not the sector indiscriminately. The actionable catalyst is the next earnings release and interim deposit/credit disclosures; absent those data, the correct posture is a monitored relative-value position rather than a directional chase.

Key Decisions for Investors

• Watch-list AX for a 1-3 month tactical long only if the next update shows sequential NIM stability or expansion, deposit-cost growth below loan-yield growth, and no upward revision to credit-cost guidance. Target a rerating toward the upper end of peer-adjusted valuation; exit on a material rise in criticized assets, net charge-offs, or deposit beta.
• Prefer a hedged expression: long AX / short KRE over 3-6 months if AX confirms funding-cost discipline. The thesis is company-specific operating leverage versus broad regional-bank CRE and deposit-beta exposure; close if AX underperforms KRE by 10% after earnings or if credit provisions begin to accelerate.
• Do not trade on the Form 4/A. Treat additional insider sales as relevant only if aggregate executive/director selling becomes persistent and is accompanied by guidance caution, loan-growth deceleration, or reserve building.
• For portfolio risk, monitor the 6-18 month lagged tightening impact through commercial real estate delinquency, consumer charge-offs, and provision-to-loan growth. A meaningful deterioration in any of these metrics would invalidate the earnings-compounding narrative and favor reducing AX exposure rather than averaging down.